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A Novel Digital Score for 
Ƥ
Lymphocytes Predicts Disease 
Free Survival in Oral Squamous Cell 
Carcinoma
Muhammad Shaban ?, Syed Ali Khurram ?, Muhammad Moazam Fraz ?ǡ ?ǡ ?, Najah Alsubaie ?ǡ ?, 
Iqra Masood ?, Sajid Mushtaq ?, Mariam Hassan ?, Asif Loya ? & Nasir M. Rajpoot ?ǡ ?ǡ ?
Oral squamous cell carcinoma (OSCC) is the most common type of head and neck (H&N) cancers with 
ǤƤ
lymphocytes (TILs) has been shown to be a key prognostic indicator in a range of cancers with emerging 
evidence of its role in OSCC progression and treatment response. However, the current methods 
of TIL analysis are subjective and open to variability in interpretation. An automated method for 
ƤƤ
ǤƤ
ǤȋȌƤ
the whole slide images (WSIs) into underlying tissue types (tumour, lymphocytes, etc.) and then 
quantifying the co-localization of lymphocytes and tumour areas in a novel fashion. We investigate the 
ƤȋƬȌ
Ǥ ? ?Ǥ ? ? ?ǡ
which paves the way for reliable downstream analysis. We show that the TILAb score is a strong 
prognostic indicator (p = ?Ǥ ? ? ? ?Ȍȋ	ȌǤ
Ƥȋp = ?Ǥ ? ? ? ?ȌǤ
ǡƤ
ǡƤ
ƤǡƤǤ
In 2014, there were more than 11,000 instances of Head and Neck (H&N) cancers in the UK and more than 
2,300 deaths resulting from oral cavity cancers1. Oral squamous cell carcinoma (OSCC) is the most common 
malignancy of the H&N region2 in both males (42%) and females (46%). he OSCC prevalence is almost twice 
as common in males and 3 times more in females than the next most common cancer which is larynx SCC (26% 
in males, 13% in females)3. OSCC is associated with invasion and destruction of local tissues and maxillofacial 
bones with signiicant associated morbidity. In addition to early recurrence, frequent lymph nodes metastasis 
and extranodal extension4 are further challenges in the management of OSCC patients. he high morbidity and 
mortality rates in OSCC patients5,6 highlight the need for an objective and quantitative analysis of any potential 
prognostic markers to help identify tumours which may respond poorly to therapy7.
 ?ǡ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Tumour -iniltrating lymphocytes (TILs) have been analysed in a wide range of cancers with strong evidence 
demonstrating their prognostic value as a supplement to the Tumour -Node-Metastasis (TNM) staging8–10. TILs 
mainly comprise T lymphocytes which migrate from the blood into the tumour as part of the body’s immune 
‘ight-back- response’. However, it is important to analyse these cells in the correct context. A large number of 
lymphocytes can be present in inlamed and cancerous tissues and, therefore, it is vital to develop methods to spe-
ciically analyse lymphocytes iniltrating the tumour as these are the ones that are likely to be of prognostic signif-
icance11–13. hese areas can be referred to as the TIL regions where both tumour and lymphocytes are co-localized 
(as illustrated in Fig. 1). Numerous studies have reported the correlation of TIL density with improved overall 
survival (OS) and longer disease-free survival14,15. It has been shown that the quantiication of spatial patterns of 
TILs in the tumour regions can have prognostic value signiicantly supplementing or even superseding the TNM 
staging in certain settings16,17. However, the currently used method of visual TIL quantiication is subjective with 
inter- and intra-observer variability and lack of diagnostic reproducibility18. herefore, it is imperative to develop 
an automated method for objective quantiication of TILs in OSCC to address these challenges.
Digitization of histology slides has recently ignited interest from computer scientists to develop techniques for 
the automated analysis of digitized multi-gigapixel whole slide images (WSIs) of tissue slides19–23. he approval of 
digitized WSIs as a primary histopathological diagnosis tool by the US Food and Drug Administration (FDA)24 
has further boosted this interest. he digitization of WSIs ofers unique opportunities to quantify vast amounts 
of information about morphological and spatial architectural patterns in WSIs and to discover novel prognostic 
and predictive histological markers to potentially improve cancer treatment25. For instance, it has recently been 
shown by Saltz et al.16 that a digital marker based on TIL spatial patterns carries prognostic signiicance for mul-
tiple cancer tissue types.
In this paper, we present a novel method to obtain an automated TIL abundance score and explore its prog-
nostic signiicance for Disease Free Survival (DFS) of OSCC patients. he proposed approach, as illustrated in 
Fig. 2, comprises of three main components: WSI segmentation into biologically signiicant tissue phenotypes, 
identiication and quantiication of TILs, and their prognostic analysis. First, WSI segmentation into biologically 
signiicant tissue phenotypes is modelled as an image patch based tissue classiication problem. Diferent tissue 
regions such as tumour, lymphocytes, and stroma in the WSI are classiied using a deep convolutional neural 
network (CNN). Second, a tumour -lymphocyte co-localization based binary classiier is developed using statis-
tical co-localization measures for detecting the presence or absence of TILs in OSCC tissue slides. he extent of 
lymphocytic iniltration, which we term as the TIL Abundance (TILAb) score, in tumour region is quantiied by 
a combination of lymphocyte-to-tumour ratio and their statistical co-localization. Finally, the prognostic signii-
cance of the TILAb score for DFS is investigated by employing univariate and multivariate analysis. To the best of 
our knowledge, there is no existing method for automated quantiication of TIL Abundance from digitized WSIs 
and the downstream analysis of OSCC patient survival. We show that the TILAb score is a strong prognostic indi-
cator of DFS in OSCC patients in agreement with previous indings based on manual TIL quantiication26. Our 
main contributions in this paper are as follows:
t A methodology for segmentation of biologically significant regions in OSCC tissue is presented which 
includes segmentation of tumour areas, lymphocytes, stromal regions, and artefacts in a WSI.
t We propose a novel scoring of TIL abundance, termed as the TILAb score, to quantify the extent of lym-
phocytic iniltration in the tumour region which is a combination of lymphocyte-to-tumour ratio and their 
statistical co-localization in a WSI.
t he reproducibility and objectivity of the TILAb score are investigated in two diferent ways: First, by ana-
lyzing the consistency between statistical co-localization based TIL detection and a pathologist’s detection. 
Second, by evaluating the prognostic signiicance of TILAb score for DFS of OSCC patients.
Materials and Methods
Ethical approval was obtained from the institutional review board (Ref. No. 17-02-17-10) at Shaukat Khanum 
Memorial Cancer Hospital and Research Centre (SKMCH&RC) and National Bioethics Committee (No.4-87/17/
NBC-234-Exempt/NBC/2592), Pakistan. All methods and experiments were carried out in accordance with rel-
evant guidelines and regulations. Exemption from written consent was granted by the IRB at SKMCH&RC and 
WSI TIL Region Tumour Lymphocytes
Figure 1. An example image of TIL region (black) in a Whole Slide Image. High resolution view of tumour 
(red) and lymphocyte (green) regions are shown in separate images.
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NBC on grounds that the data and images used in the study were already in existence and were collected and 
reported in an anonymized way ensuring conidentiality of participants. he study did not involve any interven-
tion or interaction with the participants. he research involved no more than minimal risk to the participants and 
involves no procedures for which written consent is normally required outside of the research context and the 
waiver did not adversely afect the rights and welfare of the participants.
Patient selection. Patients with OSCC diagnosed between 2010–11 at SKMCH&RC were selected from the 
electronic medical records (hospital information system). SKMCH&RC follows a multidisciplinary approach, 
therefore all patients were treated by both a radiation oncologist and by a H&N surgeon. Cases included both 
primary and recurrent tumours that underwent complete tumour resection with or without lymph node dis-
section and for which at least three year survival data were available. Ater the initial review of data, 60 patients 
were selected out of 155 oral cancer cases as per the study protocol (see Fig. S2 in the Supplementary Materials). 
he cases excluded were those with either an incomplete resection and those where survival follow up was less 
than 3 years. A inal cohort of 60 malignant cases and 10 controls were inalized where the control cases did not 
sufer from OSCC. Formalin ixed parain embedded blocks were retrieved and representative slides from each 
case were reviewed by the study pathologists (AL and SM) and conirmed to be OSCC. In addition, slides were 
also reviewed for additional histopathological features such as patterns of invasion, TILs and perineural invasion. 
For this study, oral cavity cancers were deined as carcinomas of the mouth including lip, tongue, cheeks, loor 
of the mouth, hard and sot palate, whereas tumours of the salivary glands were excluded. Ater compilation of 
the clinical and pathologic information, including American Joint Committee on Cancer (AJCC) 7th edition 
stage, clinical and pathological information was retrieved from the electronic medical records, as summarized in 
Table 1. De-identiied, tissue slides were digitally scanned in University Hospitals Coventry & Warwickshire using 
Omnyx Integrated Digital Pathology system at 40× magniication with a resolution of 0.275 µm per pixel. here 
were 193 tissue sections in 70 digitally scanned WSIs as many WSIs contain multiple tissue sections.
Patient characteristics. Our study cohort consists of 70 cases including 60 OSCC and 10 control cases. DFS 
information was available for all the malignant cases where survival time was calculated from the date of surgery. 
DFS was censored at the date of irst recurrence or death, whichever occurred irst, or the date of last contact for 
the patients alive and without recurrent disease. he follow up period ranged from 3.8 years to a maximum of 6.10 
years at the time of data retrieval (2017). Median DFS was 58 months (range, 4–86 months) and median age 50 
years (range, 25–75 years). Approximately 32% (n = 19) of patients sufered from disease recurrence whereas 22% 
(n = 13) had died by the time of data retrieval. About 60% (n = 36) of the patients were male, while 42% (n = 25) 
are at stage I/II and remaining are at stage III/IVa. Further details of all clinical parameters are given in Table 1.
Pathologist annotations. We split our OSCC cohort into two equal sized subsets, one for modelling and 
the other for test. Six cases from the modelling set were considered for validation of the proposed tissue region 
classiier. An oral and maxillofacial pathologist (SAK) reviewed all the digitized WSIs and marked the ground 
truth at two diferent level of abstraction: TIL presence or absence on all the slides, and tumour /lymphocytic 
regions on the modelling subset. At high level, the presence or absence of TILs in 193 tissue section from all WSIs 
was marked where 111 were TIL positive (T+) and 82 TIL negative (T−). For the classiication of biologically 
signiicant regions, more than half million regions (belonging to diferent classes such as tumour, lymphocytes, 
Tumour
Lymphocyte
Stroma
Non-ROI
WSI Sub-Images
Deep Neural Network
Predicons
Predicon MapTIL QuanﬁcaonPaent Straﬁcaon Tumour-Lymphocyte Overlay
Figure 2. Flow diagram of the proposed method. Colour represents the respective class.
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and stroma) were marked in all WSIs of the modelling cohort. he annotations were then used for training and 
validation of the proposed method.
Whole slide image analysis. Whole slide images are multi-gigapixel images and cannot be used directly 
for image analysis tasks particularly training a deep learning based classiier. herefore, we divide the WSIs into 
small regions (patches) for processing. A deep learning based classiier (see next section) is applied on the patches 
to identify whether the patch contains tumour, lymphocytes or other histological primitives. However, the regions 
where the lymphocytes are iniltrating the tumour may not be conined within a patch. Besides, there is con-
siderable variation in the size of TIL regions, making the quantiication of TILs a non-trivial task. We address 
this issue by adopting the widely accepted deinition of TILs, i.e., lymphocytes that lie in the neighbourhood of 
tumour areas. he patch labels predicted as lymphocytes or tumour are then used to compute a statistical meas-
ure of co-localization, which is further incorporated into the computation of the proposed score of lymphocytic 
iniltration, i.e. the TILAb score.
ƤǤ A tissue section in a WSI contains many diferent types of cells and regions, such 
as tumour cells, lymphocytes, and stromal regions (i.e. ibroblasts, endothelial cells, blood vessels, muscle, fat 
and red-blood cells). A WSI may also contain slide preparation and scanning artefacts, such as tissue folding 
and blurring, which need to be ignored. herefore, we classify OSCC tissue sections into biologically signiicant 
regions. Tumour and lymphocyte rich regions are important for the detection and quantiication of TILs. Precise 
classiication of stromal regions along with other lymphocytic regions is necessary to discriminate between 
TILs and regular lymphocytes that do not lie within the vicinity of tumour regions. he fourth and inal class 
of regions consists of scanning and tissue artefacts, which are labelled as non-regions of interest (Non-ROIs). 
We select a reasonably small patch size (128 × 128 pixels at 20×) such that we do not require precise pixel-level 
tissue segmentation. Figure 3 shows three samples of each of the 4 class labels: tumour, lymphocytes, stroma, and 
Non-ROIs.
Deep learning models have signiicantly improved the state-of-the-art in many natural image based problems 
such as visual object detection and recognition27,28 and scene labeling29. Most popular deep learning networks for 
the classiication task are ResNet30, DenseNet31, Inception32, Xception33 and MobileNet34. Each network shows 
competitive results on one of the largest image classiication datasets, ImageNet28. We train these networks for 
tissue classiication task to get a strong baseline model. We extracted 400,000 patches for training and 100,000 
patches for validation from WSIs. Both training and validation datasets have equal numbers of patches for each 
class. During training, we leverage online data augmentation with random rotation of 0, 90, 180 or 270 and ran-
dom lipping. We select the best model of each classiier ater training it for at least 125,000 optimization steps 
with RMSProp optimizer. During testing, the patch classiier takes non-overlapping patches from a WSI and out-
puts probabilities of all classes for each patch, resulting in a probability map at the WSI level. he probability maps 
are converted into prediction maps by selecting the class with the highest probability for each patch (Fig. 2). he 
prediction map at the WSI level is eventually used for TIL identiication and for computation of the TILAb score.
ƤǤ Objective quantiication of TILs is a non-trivial task as it depends on the co-localization 
of both tumour and lymphocytic regions. In ecology, co-localization of diferent species is used to understand 
their community structure35,36. Tumour and lymphocytes in TIL regions could be considered as two diferent 
interacting species in the histological landscape. We consider WSI areas containing tumour and/or lymphocytes 
Clinical Parameters Full Cohort Modelling Set Test Set
No. of Patients 60 30 30
Age (years) 49.77 ± 10.99 50.57 ± 9.77 48.97 ± 12.03
Survival (months)
Overall 54.78 ± 17.91 56.00 ± 17.75 53.47 ± 17.96
Disease Free 48.87 ± 22.51 50.00 ± 22.44 48.00 ± 22.55
Gender
Male 36 17 19
Female 24 13 11
Node-Stage
I/II 25 17 8
III/IVa 35 13 22
Grade
I/II 48 23 25
III 12 7 5
Growth Patterns
Type 1/2 21 13 8
Type 3/4 39 17 22
TILs
Absent/Mild 32 17 15
Moderate/Severe 28 13 15
Patient Status
Alive 47 24 23
Dead 13 6 7
Disease Recurrence
Yes 19 9 10
No 41 21 20
Table 1. Summary of clinical parameters of the OSCC Cohort.
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and investigate the utility of co-localization score of tumour and lymphocytes in the WSI. For this purpose, a WSI 
is divided into m × n equal sized grids, such that the grid size is greater than the size of input patch for the region 
classiier. he co-localization score M in terms of the Morisita-Horn37 index is then deined as follows,
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where p
ij
l  and p
ij
t represent the percentage of lymphocytic and tumour regions in the (i, j)th grid-cell, respectively 
(Fig. 4). If a grid-cell does not contain any tumour and lymphocytic region, then it would not contribute towards 
the co-localization score. However, if a grid-cell only contains one type of region, either tumour or lymphocyte, 
then it only contributes to the denominator of the equation thus results in a relatively small value of the 
co-localization score. If all the grid-cells contain only unique type of regions, then the co-localization score 
become zero. his score ranges from 0 to 1 and the score is maximum when each of the grid-cells has exactly the 
same number of tumour and lymphocyte patches, as shown in Fig. 4.
We also consider the Shannon diversity index38 to quantify the co-localization of tumour and lymphocytic 
regions in a WSI. It computes the diversity of two classes in a given region that is also aligned with the above 
deinition of TILs. For m × n grids of equal sizes in a WSI, the Shannon diversity index, S, is deined as follow,
Tumour Lymphocytes
Stroma Non-ROI
Figure 3. Exemplar patches of tumour, lymphocyte, stroma, and Non-ROI (artefacts) classes.
Morisita: 0 TILAb: 0 Morisita: 1 TILAb: 0.5 Morisita: 0.6 TILAb: 0.9
Lymphocyte Region Tumour Region
Figure 4. he illustration of tumour and lymphocyte co-localization patterns, each image is divided into 4 × 4 
grids. (Let) Highly segregated appearance of tumour and lymphocytic regions. (Center) Fully co-localized 
regions. (Right) Lymphocyte rich co-localization.
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where p
ij
l  and p
ij
t represent the percentage of lymphocytic and tumour regions in the (i, j)th grid-cell. The 
co-localization computed using Shannon diversity index is relatively smaller in magnitude as compared to the 
Morisita-Horn index with the maximum value of 0.7 at the maximum co-localization point of tumour and lym-
phocytic regions (Fig. 5).
The proposed TILAb score. he Morisita-Horn and Shannon diversity are two objective and eicient meas-
ures for quantiication of co-localization. However, these methods give equal importance to all the constituent 
classes (or species), which consequently results in a symmetric co-localization score (as can be seen in Fig. 5). For 
instance, 20% lymphocytes and 80% tumour in a region will give the same co-localization score as another region 
consisting of 80% lymphocytes and 20% tumour. However, the lymphocyte proliferation in tumour is considered 
to be good prognostic indicator for patient survival. herefore, the symmetric nature of these measures is not 
ideal for obtaining an objective TIL abundance score of prognostic importance. We proposed the TIL abundance 
(TILAb) score, T, which is a combination of the lymphocyte-to-tumour ratio and their co-localization, as deined 
below,
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where C is a co-localization measure and M or S can be used as a co-localization measure. Right half of the above 
equation shows the lymphocytes-to-tumour ratio in WSI. We normalize the range of TILAb score between 0 to 
1 by dividing it by a factor of 2. he proposed TILAb score objectively quantiies the TILs and its formulation is 
generic enough to work with both Morisita-Horn and Shannon diversity indices. Figure 5 shows the distribu-
tion of TILAb score using Morisita-Horn index based co-localization at diferent percentages of lymphocytes. It 
can be seen that both Morisita-Horn and Shannon diversity indices have relatively small values even with high 
lymphocytic percentage, whereas the TILAb score increases with the increase in lymphocytic iniltration (See 
Supplementary Section 1). Moreover, TILAb score remains same for diferent tumour and lymphocyte density 
with same ratio (See Fig. S3).
Survival analysis. he TILAb score based statistical analysis is performed for DFS in order to demonstrate 
its prognostic signiicance as an independent biomarker. Kaplan-Meier39 and Cox proportional-hazards model40 
are used for survival and hazard analyses, respectively. To stratify patients into high-risk (short-term survival) and 
low-risk (long-term survival) groups, we ind an optimal cut-point on the TILAb score value from the modelling 
subset where the statistical signiicance of the diference in DFS between the two groups is the largest. Log-rank 
test based p value is used to assess the statistical signiicance of the survival stratiication observed between cases 
predicted to be short-term and long-term DFS where p < 0.05 is considered signiicant. For multivariate analysis, 
Cox proportional-hazards model is used which simultaneously evaluates the efect of several factors on survival. 
We report the hazard ratio along with lower and upper 95% conidence interval. Global statistical signiicance of 
the model is measured by the Wald test.
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Figure 5. Plots of Morisita-Horn, Shannon diversity and TILAb indices for diferent percentages of 
lymphocyte. At each point, the percentage of tumour is equal to 1 – percentage of lymphocyte.
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Implementations. We made use of the open source Keras and Tensorlow libraries to train our tissue region 
classiier network. All the training is done on Scan 3XS computer with Intel(R) Xeon(R) processor (E5-2690) and 
two NVIDIA TitanX 12GB GPUs. he trained model is then used to get the probability maps of WSI images. he 
lymphocytes and tumour probability maps are used to compute the TILAb score according to the Eq. (3). All the 
statistical analysis including p-values, c-index, Kaplan-Meier and Cox proportional-hazards analysis are done 
using standard R packages i.e. survival, cvAUC, ROCR, and survMisc.
Results
Tissue region classification. In order to get a strong baseline multi-class Tissue Region Classifier 
(TRC) model, we employ ive state-of-the-art convolutional neural network models (ResNet5030, DenseNet31, 
Inception32, Xception33 and MobileNet34), denoted as TRC-1 to TRC-5 respectively. Table 2 gives the quantita-
tive performance of these TRCs for multi-class patch level classiication on the validation dataset; details of the 
comparative performance analysis can be found in Table S1 in the Supplementary Materials. Among the ive clas-
siiers, MobileNet (TRC-5) shows superior performance as compared to the other networks. It is a light-weight 
network that leverages separable convolutions to reduce the number of required parameters and computations, 
resulting in consumption of relatively less memory and computational resources and making it an attractive 
choice for the processing of multi-gigapixel whole slide images. For evaluation of proposed approach, we used 
both the best performing (TRC-5) and the least performing (TRC-1) tissue region classiiers for downstream 
analysis.
Sample visual results for tissue region classiication obtained with TRC-5 are shown for illustration in Figs 6 
and S4, where tumour, lymphocytic, stromal and non-ROI regions are shown in diferent colours â€“ see detailed 
confusion matrix in Fig. S5 in the Supplementary Materials. Lymphocytic regions are classiied with the highest 
accuracy whereas tumour and non-ROI regions show slight overlap. In general, TRC-5 gives the best classiica-
tion performance, as can also be seen in the Precision-Recall curve in Fig. S6, which shows relatively high values 
of True Positive Rate (TPR) and low values for False Positive Rate (FPR) for both tumour and lymphocyte areas.
ƤǤ he score for co-localization of tumour and lymphocytes for each 
tissue section is computed using the Eq. (1). he TILAb score at WSI level is also computed according to Eq. 
(3) and later used for the survival analysis. Figures 7 and S7 show the co-localization scores of diferent tissue 
segments in the WSI along with the WSI level TILAb score. For evaluating the TILAb score’s performance with 
manual marking, tissue segments on a WSI are marked for the presence (T+) and absence (T−) of TILs by an 
expert pathologist (SAK). Five diferent performance measures are used to evaluate the performance of the pro-
posed method, as shown in Table 3. Co-localization score based on the best performing region classiier (TRC-5) 
achieved 88.96% Area Under the Curve (AUC). It is pertinent to mention that the least performing region classi-
ier (TRC-1) also performed reasonably well with 87.54% AUC.
Survival analysis. he prognostic signiicance of TILAb score for DFS is investigated using Kaplan-Meier 
(KM) curves and Cox hazard analyses by conducting univariate and multivariate analysis of digital, clinical, 
and pathological parameters. We propose the TILAb score based prognostic model to predict the binary out-
come of DFS. he prognostic model inds the optimal cut-of point for TILAb score on the modelling subset 
and uses that cut-of on the test subset for binary prediction. he proposed TIL quantiication method con-
tains one hyper-parameter which is the size of a grid-cell. We experimented with eight diferent neighbour-
hood sizes on tissue section to investigate their impact on survival analysis. he size of the smallest grid-cell 
is 0.28 mm × 0.28 mm and we used a ixed step size of 0.14 mm for increment in grid-cell size, up to the largest 
grid-cell of size 1.2 mm × 1.2 mm. Table 4 shows that our proposed TILAb score is statistically signiicant for all 
sizes with both best and least performing tissue region classiiers (TRC-1 and TRC-5). However, the standard 
non-normalized Morisita-Horn and Shannon diversity measures show signiicant results only for the smallest 
grid-cell size when using the best performing region classiier (TRC-5). his indicates the signiicance of TILAb 
score for DFS analysis. Moreover, the high concordance indices (c-indices) of the prognostic models are also evi-
dence of the predictive ability of proposed models. Tables 5 and S2 (in Supplementary Materials) lists the c-index 
value for both DFS and OS models. Models for DFS achieve high c-index value as compare to the models for OS. 
On the other hand, models with diferent colocalization methods (TILAb-MH, TILAb-SD) show similar results 
within DFS and OS. Kaplan-Meier curves in Fig. 8 show that the proposed TILAb score is signiicantly associated 
with long term (low risk) DFS of OSCC patients (p = 0.00062). However, the lymphocytic percentage in a WSI 
without any correlation with tumour does not show any statistical signiicance. he proposed digital TILAb score 
has higher statistical signiicance as compared to the manual TIL score given by expert pathologists (SM and AL) 
ater visual inspection. Kaplan-Meier curves for other clinical and pathological parameters are shown in Fig. S8.
Classiiers Accuracy Sensitivity Speciicity F1-Score AUC
TRC-1 (ResNet5030) 94.04 88.19 96.03 88.08 97.88
TRC-2 (DenseNet31) 95.40 90.80 96.94 90.78 98.56
TRC-3 (Inception-v332) 95.84 91.91 97.25 91.70 98.86
TRC-4 (Xception33) 95.94 92.16 97.32 91.88 98.83
TRC-5 (MobileNet34) 96.31 92.66 97.55 92.62 98.91
Table 2. Quantitative performance of ive diferent tissue region classiiers on validation dataset of 105 patches.
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Results of the univariate analysis of prognostic signiicance of digital, clinical and pathological parameters 
on the test subset are shown in Fig. 9. We employed Cox proportional hazards method for univariate analysis 
for both quantitative and categorical predictor variables. he clinical parameters do not show any signiicant 
Figure 6. Tissue region classiication results by TRC-5 where tumour, lymphocytic, stromal and non-ROI 
regions are represented by red, green, blue and black colours, respectively.
5 mm 5 mm
0.2388
0.0763
0.4686
0.1183
TILAb = 0.2283
ba
Figure 7. (a) Whole slide image at low resolution (1.5×) with tumour and lymphocytic region predictions 
overlaid in red and green colours, respectively. (b) Tumour -lymphocyte co-localization map along with co-
localization score for each tissue section in upper right corner and WSI level TILAb score. Colour codes map 
the co-localization score to respective tissue sections.
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correlation with DFS, with the conidence interval range of hazard ratios (lower and upper 95% bounds) being 
quite large, except for age. he pathological parameters show better association with DFS as compared to clini-
cal parameters especially tumour grade and manual quantiication of TILs. Among digital scores, the proposed 
TILAb score is shown to be statistically signiicant (p = 0.0065) with hazard ratio of 0.0001 (1.446 × 107 − 0.0769). 
We also investigate the prognostic value of the TILAb score in the context of other pathological parameters such 
as grade, stage and patterns, as shown in Table 6. For this purpose, we conduct the multivariate Cox proportional 
hazards analysis using the TILAb score adjusted by other histological features, as shown in Table 6. TILAb score 
is signiicant when combined with pathological features. Additionally, TILAb score is also signiicant when com-
bined with grade, stage or pattern.
Discussion and Conclusion
he presence of lymphocytes in the vicinity of tumour cells has been reported to carry high prognostic value14,15. 
Quantiication of TILs can not only signiicantly supplement the clinical cancer staging information but could be 
used as an accurate predictor of disease progression8–10. he abundance of TILs in a tissue slide (or its digitized 
WSI) indicates the host immune response against cancer and/or response to treatment. he density and spatial 
arrangement of TILs is correlated with improved overall survival (OS) and longer DFS. However, the manual 
quantiication of TIL abundance is subjective, leading to inter-/intra- observer variability and lacking diagnostic 
reproducibility.
We propose a deep learning based approach for identiication and quantiication of TILs in OSCC cases. 
A digital score of TIL Abundance is computed and its prognostic potential is investigated for DFS in OSCC 
patients. he biologically signiicant regions in tissue such as tumour, lymphocytes, and stroma are classiied 
using convolutional neural network. Several techniques are available in literature for detection and classiication 
of histological structures in WSI images19,41–45. However, very few are used for downstream prognostic analysis 
for DFS. In this study, the results of tumour and lymphocytic region classiication are used to compute the TIL 
abundance score (TILAb) followed by its evaluation as a prognostic marker. For tissue region classiication, we 
experiment with diferent state-of-the-art CNN based image classiiers. We have chosen the classiiers giving the 
Classiiers Accuracy Sensitivity Speciicity F1-Score AUC (95% CI)
TRC-1 80.19 85.45 74.51 81.74 87.54 (80.95–94.12)
TRC-5 79.05 79.69 78.05 82.26 88.96 (82.68–95.13)
Table 3. Performance of tissue section classiication into TIL positives and negatives.
Region 
Classiier
Quantiication 
Methods 1 2 3 4 5 6 7 8
TRC-1
Morisita-Horn (MH) 0.1590 0.1610 0.1560 0.3250 0.2340 0.4760 0.4760 0.4760
Shannon Diversity (SD) 0.1590 0.1610 0.1610 0.3250 0.2190 0.6550 0.4760 0.4760
TILAb-MH 0.0146 0.0258 0.0146 0.0012* 0.0258 0.0006* 0.0020* 0.0006**
TILAb-SD 0.0146 0.0146 0.0258 0.0146 0.0258 0.0258 0.0006** 0.0006**
TRC-5
Morisita-Horn (MH) 0.0416 0.0666 0.1030 0.1800 0.0666 0.1800 0.2340 0.1790
Shannon Diversity (SD) 0.0416 0.0666 0.0666 0.1160 0.0666 0.1800 0.2340 0.1790
TILAb-MH 0.0191 0.0191 0.0077* 0.0077* 0.0258 0.0236 0.0020* 0.0038*
TILAb-SD 0.0191 0.0359 0.0146 0.0258 0.0110 0.0146 0.0020* 0.0020*
Table 4. Comparison of the diferent TIL quantiication methods based on their prognostic signiicance 
(logrank test based p-values) at diferent grid-cell sizes (smallest to largest). [a] Signiicance codes: 0.05, 0.01*, 
0.001**.
Grid-Cell
TRC-1 TRC-5
TILAb-MH TILAb-SD TILAb-MH TILAb-SD
C-Index Lower CI Upper CI C-Index Lower CI Upper CI C-Index Lower CI Upper CI C-Index Lower CI Upper CI
1 0.8700 0.7489 0.9911 0.8700 0.7489 0.9911 0.8650 0.7297 1.0000 0.8650 0.7297 1.0000
2 0.8700 0.7497 0.9903 0.8650 0.7416 0.9884 0.8450 0.7093 0.9807 0.8450 0.7079 0.9821
3 0.8550 0.7265 0.9835 0.8500 0.7182 0.9818 0.8400 0.7020 0.9780 0.8500 0.7167 0.9833
4 0.8400 0.6999 0.9801 0.8500 0.7182 0.9818 0.8450 0.7086 0.9814 0.8450 0.7086 0.9814
5 0.8450 0.7086 0.9814 0.8450 0.7065 0.9835 0.8350 0.6921 0.9779 0.8400 0.6999 0.9801
6 0.8300 0.6825 0.9775 0.8350 0.6894 0.9806 0.8400 0.6999 0.9801 0.8350 0.6908 0.9792
7 0.8300 0.6825 0.9775 0.8300 0.6825 0.9775 0.8350 0.6934 0.9766 0.8250 0.6750 0.9750
8 0.8200 0.6696 0.9704 0.8250 0.6725 0.9775 0.8400 0.6992 0.9808 0.8500 0.7160 0.9840
Table 5. C-Indices (with 95% CI) of TRC-1 and TRC-5 based prognostic models for DFS at diferent grid-cell 
sizes (smallest to largest).
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highest (TRC-5) and the lowest (TRC-1) patch level classiication accuracy for further analysis of TIL detection, 
computing the abundance score and survival analysis. he results obtained by both of the classiiers are statisti-
cally signiicant.
Detection of clinically signiicant histopathological regions is followed by the detection and quantiication 
of TILs. In this regard, Saltz et al.16 have studied the correlation between TIL spatial organization and molecular 
characteristics in histology images. hey have used CNN for detection of lymphocytes in tissue regions, which 
they referred to as TILs. In contrast, we considered only those lymphocytes as TILs that have iniltrated into (or 
are co-localized with) tumour regions. Moreover, Saltz et al. used ainity propagation algorithm to identify/
quantify the local spatial patterns in the detected lymphocytes for survival analysis. In this work, the iniltration 
of lymphocytes in the tumour region is quantiied by employing normalized versions of statistical co-localization 
Figure 8. Kaplan Meier (KP) curves for disease free survival of OSCC on test subset. Top row contains the KP 
curves for pathological parameters (stage, grade, and manual TIL quantiication) whereas bottom row shows the 
KP curves of digital parameters (Lymphocyte percentage in WSI, TILAb score using TRC-1 and TRC-5). he 
optimal cut-point values for digital parameters are 0.017, 0.124 and 0.137, respectively.
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Figure 9. Univariate analysis for clinical (red), pathological (green) and digital (blue) parameters. Hazard ratios 
are represented by a illed circle whereas edges of each line represent the lower and upper conidence interval of 
0.95%. p-value using Wald test is shown on the right end for each parameter. Digital parameters are computed 
using TRC-5 predictions.
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measures of Morisita-Horn37 and Shannon Diversity38 indices. Recently, some studies have used ecological meas-
ures like Morisita-Horn and Getis-Ord46 for quantifying immune-cancer co-localization and hotspot analysis. For 
instance, Maley et al.47 have reported the immune-cancer co-localization as a prognostic factor for breast cancer. 
Nawaz et al.48 have used hotspot analysis to identify the statistically signiicant hotspots of cancer and immune 
cells. Both of the above studies used handcrated feature-based machine learning methods for identiication of 
tumour and immune cell areas. In contrast, we have used a deep learning based approach for identifying tumour 
and lymphocyte rich regions at patch level which have been shown to be more accurate. Moreover, the normal-
ized TIL abundance score is computed as a combination of lymphocyte-to-tumour ratio and their statistical 
co-localization in a WSI. In summary, the proposed TILAb score is a digital biomarker which is based on more 
accurate classiication of tumour and lymphocytic regions, is motivated by the biological deinition of TILs as 
tumour iniltrating lymphocytes, and is objective and reproducible.
he prognostic signiicance of this score for DFS is investigated by employing univariate and multivariate 
analyses using clinico-pathological parameters. We analyse the prognostic signiicance of the TILAb score using 
Cox proportional hazard model. he TILAb score shows good statistical signiicance in both univariate (Table 4) 
and multivariate (Table 6) analyses (p < 0.05). herefore, the TILAb score can be used as an independent prog-
nostic parameter in OSCC patients. he Kaplan-Meier curves showed the ability of TILAb score to stratify patents 
into long-term (low risk) and short-term (high risk) DFS (p = 0.0006). Although the main focus of the paper 
is on DFS, besides DFS the prognostic signiicance of TILAb score for overall survival is also investigated. he 
Kaplan Meier curves are shown in Fig. S9 in the supplementary material which illustrates that the TILAb score 
gives good separation for overall survival too. To highlight the independence of the proposed model on initial 
image selection, the 3-fold cross validation with random initial image selection is used for DFS. he KM curves 
and associated p-values, shown in Fig. 10, illustrate that the proposed models (TRC-1 and TRC-5) are prognos-
tically signiicant for diferent sets of training and test splits. Moreover, to show the robustness of our method, 
the C-indices (with 95% conidence intervals) of prognostic models for disease free survival and overall survival 
are also computed and shown in Tables 5 and S2 respectively. he results of the proposed method are also in 
agreement with previous indings based on manual and immunohistochemistry based TIL quantiication26,49,50 
in OSCC. Fang et al.50 analysed the prognostic signiicance of tumour iniltrating immune cell in OSCC. he 
immune cells were identiied by their speciic markers (CD8, CD4, T-bet, CD68 and CD57). High CD8 (T-cells) 
and CD57 (NK-cell) expression were signiicantly associated with longer survival.
Hematoxylin & Eosin staining is routinely used in pathology labs around the globe in clinical practice for 
cancer diagnostics. Automated methods for extracting information related to TILs from the whole slide images 
can help in treatment planning according to the immune response. he proposed framework for automated quan-
tiication of TILs, computation of their abundance score, and its prognostic analysis of patient survival using 
OSCC histology images is the irst of its kind. Even though the total number of cases involved in this study is 
limited (n = 70), some other studies have reported results on smaller cohorts51 (n = 48) or using tissue microar-
rays52 (TMAs), which contain much smaller snapshots of tumour /lymphocytes characteristics as compared to 
the whole slide images. Having said that, the results of this study need to be cross-validated on data from large 
multi-centric patient cohorts before they can be adopted in clinical practice.
In addition to the application to cancer resections and information about future behaviour, our proposed 
TILAb score can be applied to the initial biopsy specimen undertaken before surgical resection or chemoradio-
therapy. A biopsy and histological assessment is the gold standard for pre-operative diagnosis and a prerequisite 
for staging. As part of this assessment, pathologists report the presence/absence and comment on the density of 
the host lymphocytic response. he TILAb score can provide an objective quantiication on this initial biopsy 
providing vital information about prognosis to the clinical team with the potential to guide treatment decisions 
and risk stratiication.
p HR Lower 95% Upper 95%
A - Overall Signiicance (0.0334)
TILAb 0.0103 3.423e05 1.321e08 0.0887
Grade 0.3625 1.9720 0.4574 8.5003
Stage 0.2307 1.5280 0.7637 3.0587
Pattern 0.9387 1.0370 0.4105 2.6196
B - Overall Signiicance (0.0090)
TILAb 0.0085 6.701e5 5.232e08 0.0858
Grade 0.0745 2.3810 0.9177 6.1798
C - Overall Signiicance (0.0128)
TILAb 0.0061 3.267e05 2.044e08 0.0522
Stage 0.1377 1.6610 0.8499 3.2466
D - Overall Signiicance (0.0105)
TILAb 0.0038 2.243e05 1.610e08 0.0313
Pattern 0.1324 1.6750 0.8555 3.2803
Table 6. Multivariate analysis of TILAb score along with other clinical parameters. TILAb score is computed 
with the Morisita-Horn as co-localization measure on TRC-5 predictions, while the p-value is computed using 
the Wald test.
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Code and Data Availability
he code of the proposed method is publicly available on github (https://github.com/TIA-Lab/TILAb-Score). We 
plan to release all the annotated data in the public domain, should this paper be accepted for publication.
References
 1. Cancer statistics for the UK (2018).
 2. Shield, K. D. et al. he global incidence of lip, oral cavity, and pharyngeal cancers by subsite in 2012. CA: a cancer journal for 
clinicians 67, 51–64 (2017).
 3. Head and neck cancers incidence statistics - cancer research uk. https://www.cancerresearchuk.org/health-professional/cancer-
statistics/statistics-by-cancer-type/head-and-neck-cancers/incidence#heading-Four. Accessed: 2019-03-10.
 4. Krishna, A. et al. Demographic risk factors, affected anatomical sites and clinicopathological profile for oral squamous cell 
carcinoma in a north Indian population. Asian Pac. J. Cancer Prev. 15, 6755–6760 (2014).
 5. Liu, L., Kumar, S. K., Sedghizadeh, P. P., Jayakar, A. N. & Shuler, C. F. Oral squamous cell carcinoma incidence by subsite among 
diverse racial and ethnic populations in California. Oral Surgery, Oral Medicine, Oral Pathol. Oral Radiol. Endod. 105, 470–480 
(2008).
 6. Oliveira, M. L. C. et al. A 10-year analysis of the oral squamous cell carcinoma proile in patients from public health centers in 
Uruguay. Braz. oral research 29, 1–8 (2015).
 7. Braakhuis, B. J., Brakenhof, R. H. & Leemans, C. R. Second ield tumors: a new opportunity for cancer prevention? he Oncol. 10, 
493–500 (2005).
 8. Bryne, M. Is the invasive front of an oral carcinoma the most important area for prognostication? Oral diseases 4, 70–77 (1998).
 9. Bryne, M., Koppang, H. S., Lilleng, R. & Kjærheim, Å. Malignancy grading of the deep invasive margins of oral squamous cell 
carcinomas has high prognostic value. he J. pathology 166, 375–381 (1992).
 10. Kurokawa, H. et al. he high prognostic value of the histologic grade at the deep invasive front of tongue squamous cell carcinoma. 
J. oral pathology & medicine 34, 329–333 (2005).
 11. Peled, M., Onn, A. & Herbst, R. S. Tumor-iniltrating lymphocytes—location for prognostic evaluation. Clin. Cancer Res. 25, 
1449–1451 (2019).
 12. Zhou, C. et al. Density and location of cd 3+ and cd 8+ tumor-iniltrating lymphocytes correlate with prognosis of oral squamous 
cell carcinoma. J. Oral Pathol. & Medicine 47, 359–367 (2018).
 13. Catacchio, I. et al. Intratumoral, rather than stromal, cd8+ t cells could be a potential negative prognostic marker in invasive breast 
cancer patients. Transl. oncology 12, 585–595 (2019).
 14. Angell, H. & Galon, J. From the immune contexture to the Immunoscore: the role of prognostic and predictive immune markers in 
cancer. Curr. opinion immunology 25, 261–267 (2013).
 15. Fridman, W. H., Pagès, F., Sautès-Fridman, C. & Galon, J. he immune contexture in human tumours: impact on clinical outcome. 
Nat. Rev. Cancer 12, nrc3245 (2012).
 16. Saltz, J. et al. Spatial organization and molecular correlation of tumor-iniltrating lymphocytes using deep learning on pathology 
images. Cell reports 23, 181 (2018).
 17. Corredor, G. et al. Spatial architecture and arrangement of tumor-iniltrating lymphocytes for predicting likelihood of recurrence in 
early-stage non-small cell lung cancer. Clin. Cancer Res. clincanres–2013 (2018).
 18. Andrion, A. et al. Malignant mesothelioma of the pleura: interobserver variability. J. clinical pathology 48, 856–860 (1995).
 19. Bejnordi, B. E. et al. Diagnostic assessment of deep learning algorithms for detection of lymph node metastases in women with 
breast cancer. Jama 318, 2199–2210 (2017).
 20. Graham, S. & Rajpoot, N. SAMS-NET: Stain-aware multi-scale network for instance-based nuclei segmentation in histology images. 
In Biomedical Imaging (ISBI 2018), 2018 IEEE 15th International Symposium on, 590–594 (IEEE, 2018).
 21. Qaiser, T. et al. HER 2 challenge contest: a detailed assessment of automated her 2 scoring algorithms in whole slide images of breast 
cancer tissues. Histopathol. 72, 227–238 (2018).
 22. Whitney, J. et al. Quantitative nuclear histomorphometry predicts oncotype DX risk categories for early stage ER+ breast cancer. 
BMC cancer 18, 610 (2018).
 23. Lu, C. et al. An oral cavity squamous cell carcinoma quantitative histomorphometric-based image classiier of nuclear morphology 
can risk stratify patients for disease-speciic survival. Mod. Pathol. 30, 1655 (2017).
 24. Caccomo, S. FDA allows marketing of irst whole slide imaging system for digital pathology. fda news release (2017).
 25. Snead, D. R. et al. Validation of digital pathology imaging for primary histopathological diagnosis. Histopathol. 68, 1063–1072 
(2016).
 26. de Ruiter, E. J., Oot, M. L., Devriese, L. A. & Willems, S. M. he prognostic role of tumor iniltrating T-lymphocytes in squamous 
cell carcinoma of the head and neck: A systematic review and meta-analysis. OncoImmunology 6, e1356148, https://doi.org/10.1080
/2162402X.2017.1356148 (2017).
 27. Ren, S., He, K., Girshick, R. & Sun, J. Faster r-cnn: Towards real-time object detection with region proposal networks. In Advances 
in neural information processing systems, 91–99 (2015).
 28. Krizhevsky, A., Sutskever, I. & Hinton, G. E. ImageNet classiication with deep convolutional neural networks. In Advances in neural 
information processing systems, 1097–1105 (2012).
Figure 10. Kaplan Meier (KP) curves for disease free survival of OSCC on 3-fold cross-validation using TRC-1 
and TRC-5.
13SCIENTIFIC REPORTS |         (2019) 9:13341  | ǣȀȀǤȀ ? ?Ǥ ? ? ? ?Ȁ ? ? ? ? ?Ǧ ? ? ?Ǧ ? ? ? ? ?Ǧ
www.nature.com/scientificreportswww.nature.com/scientificreports/
 29. Farabet, C., Couprie, C., Najman, L. & LeCun, Y. Learning hierarchical features for scene labeling. IEEE transactions on pattern 
analysis machine intelligence 35, 1915–1929 (2013).
 30. He, K., Zhang, X., Ren, S. & Sun, J. Deep residual learning for image recognition. In Proceedings of the IEEE conference on computer 
vision and pattern recognition, 770–778 (2016).
 31. Huang, G., Liu, Z., van der Maaten, L. & Weinberger, K. Q. Densely connected convolutional networks. In 2017 IEEE Conference on 
Computer Vision and Pattern Recognition (CVPR), 2261–2269 (IEEE, 2017).
 32. Szegedy, C., Vanhoucke, V., Iofe, S., Shlens, J. & Wojna, Z. Rethinking the Inception architecture for computer vision. In Proceedings 
of the IEEE Conference on Computer Vision and Pattern Recognition, 2818–2826 (2016).
 33. Chollet, F. Xception: Deep learning with depthwise separable convolutions. arXiv preprint (2016).
 34. Howard, A. G. et al. Mobilenets: Efficient convolutional neural networks for mobile vision applications. arXiv preprint 
arXiv:1704.04861 (2017).
 35. McIntosh, A. R., Peckarsky, B. L. & Taylor, B. W. Predator-induced resource heterogeneity in a stream food web. Ecol. 85, 2279–2290 
(2004).
 36. Scalon, J. D., Avelar, M. B. L., Alves, G.D. F. & Zacarias, M. S. Spatial and temporal dynamics of cofee-leaf-miner and predatory 
wasps in organic cofee ield in formation. Ciˆencia Rural. 41, 646–652 (2011).
 37. Horn, H. S. Measurement of overlap in comparative ecological studies. he Am. Nat. 100, 419–424 (1966).
 38. Shannon, C. E. A mathematical theory of communication. ACM SIGMOBILE Mob. Comput. Commun. Rev. 5, 3–55 (2001).
 39. Kaplan, E. L. & Meier, P. Nonparametric estimation from incomplete observations. J. Am. statistical association 53, 457–481 (1958).
 40. Cox, D. R. Regression models and life-tables. In Breakthroughs in statistics, 527–541 (Springer, 1992).
 41. Sirinukunwattana, K. et al. Locality sensitive deep learning for detection and classiication of nuclei in routine colon cancer histology 
images. IEEE transactions on medical imaging 35, 1196–1206 (2016).
 42. Xu, J. et al. Stacked sparse autoencoder (SSAE) for nuclei detection on breast cancer histopathology images. IEEE transactions on 
medical imaging 35, 119–130 (2016).
 43. Li, C., Wang, X., Liu, W. & Latecki, L. J. Deepmitosis: Mitosis detection via deep detection, veriication and segmentation networks. 
Med. image analysis 45, 121–133 (2018).
 44. Chen, H. et al. Dcan: Deep contour-aware networks for object instance segmentation from histology images. Med. image analysis 36, 
135–146 (2017).
 45. Javed, S., Fraz, M. M., Epstein, D., Snead, D. & Rajpoot, N. M. Cellular community detection for tissue phenotyping in histology 
images. In Computational Pathology and Ophthalmic Medical Image Analysis, 120–129 (Springer, 2018).
 46. Getis, A. & Ord, J. K. he analysis of spatial association by use of distance statistics. Geogr. analysis 24, 189–206 (1992).
 47. Maley, C. C., Koelble, K., Natrajan, R., Aktipis, A. & Yuan, Y. An ecological measure of immune-cancer colocalization as a prognostic 
factor for breast cancer. Breast Cancer Res. 17, 131 (2015).
 48. Nawaz, S., Heindl, A., Koelble, K. & Yuan, Y. Beyond immune density: critical role of spatial heterogeneity in Estrogen Receptor-
negative breast cancer. Mod. Pathol. 28, 766 (2015).
 49. Partlová, S. et al. Distinct patterns of intratumoral immune cell iniltrates in patients with hpv-associated compared to non-virally 
induced head and neck squamous cell carcinoma. Oncoimmunology 4, e965570 (2015).
 50. Fang, J. et al. Prognostic signiicance of tumor iniltrating immune cells in oral squamous cell carcinoma. BMC cancer 17, 375 (2017).
 51. Honkanen, T. J. et al. Prognostic and predictive role of spatially positioned tumour iniltrating lymphocytes in metastatic HER2 
positive breast cancer treated with trastuzumab. Sci. reports 7, 18027 (2017).
 52. Lu, C. et al. Nuclear shape and orientation features from H&E images predict survival in early-stage Estrogen Receptorpositive 
breast cancers. Lab. Investig. 1 (2018).
Author Contributions
N.M.R. and A.L. conceived and designed the study. A.L. and S.M. provided substantial contribution to selection 
of clinical parameters and both were involved in manual TILs scoring whereas S.A.K. annotated the digital slides. 
M.H. was involved in drating parts of protocol clinical methodology, patient selection, clinical data collection 
and analysis. I.M. was involved in clinical data collection and project coordination. M.S. implemented the 
proposed method and conducted all the experiments for TIL quantiication under direct supervision of N.M.R.; 
M.S. and N.A. conducted the survival analysis. M.S., S.A.K. and N.M.R. analysed the experimental results. M.S., 
M.M.F., S.A.K. and N.M.R. wrote the initial drat of the paper, which was then revised and approved by all other 
authors.
Additional Information
Supplementary information accompanies this paper at https://doi.org/10.1038/s41598-019-49710-z.
Competing Interests: he authors declare no competing interests.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and 
institutional ailiations.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International 
License, which permits use, sharing, adaptation, distribution and reproduction in any medium or 
format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Cre-
ative Commons license, and indicate if changes were made. he images or other third party material in this 
article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the 
material. If material is not included in the article’s Creative Commons license and your intended use is not per-
mitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the 
copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
 
© he Author(s) 2019
